Brainstorm Cell Therapeutics Inc BCLI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
0.5396quote price arrow up+0.0051 (+0.9542%)
Volume
79,168
52 week range
0.13 - 3.34
Loading...
  • Open0.542
  • Day High0.5525
  • Day Low0.5238
  • Prev Close0.5345
  • 52 Week High3.34
  • 52 Week High Date06/06/23
  • 52 Week Low0.13
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap36.877M
  • Shares Out68.34M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.31
  • YTD % Change97.66

KEY STATS

  • Open0.542
  • Day High0.5525
  • Day Low0.5238
  • Prev Close0.5345
  • 52 Week High3.34
  • 52 Week High Date06/06/23
  • 52 Week Low0.13
  • 52 Week Low Date10/31/23
  • Market Cap36.877M
  • Shares Out68.34M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.31
  • YTD % Change97.66

RATIOS/PROFITABILITY

  • EPS (TTM)-0.41
  • P/E (TTM)-1.32
  • Fwd P/E (NTM)-1.54
  • EBITDA (TTM)-21.174M
  • ROE (TTM)-1,121.90%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Brainstorm Cell Therapeutics Inc

 

Profile

MORE
BrainStorm Cell Therapeutics Inc. is a developer of autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The neurodegenerative diseases include Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzheimer’s disease (AD), and others. The Company is engaged in the clinical development and commercialization of the NurOwn technology platform used to produce autologous mesenchymal stem cells- neurotrophic factors (MSC-NTF)...
Jacob Frenkel Ph.D.
Independent Chairman of the Board
Chaim Lebovits
President, Chief Executive Officer
Alla Patlis CPA
Chief Financial Officer, Controller
Ibrahim Dagher M.D.
Executive Vice President, Chief Medical Officer
Uri Yablonka
Executive Vice President, Chief Business Officer, Secretary, Director
Address
1325 Avenue Of Americas, 28Th Floor
New York, NY
10019
United States

Top Peers

SYMBOLLASTCHG%CHG
XLO
Xilio Therapeutics Inc
1.04-0.05-4.59%
NXTC
NextCure Inc
1.17-0.18-13.33%
EFTR
eFFECTOR Therapeutics Inc
2.07+0.18+9.52%
TARA
Protara Therapeutics Inc
3.10+0.18+5.98%
CKPT
Checkpoint Therapeutics Inc
1.44+0.01+0.35%